Domanex's CEO, Eddy Littler Talks to PharmaTelevision about Domainex's work with ZoBio

Domainex spoke with PharmaTelevision in December 2014 to explain:

  • the collaboration with ZoBio and the combination of Domainex's CDH technology with ZoBio's state-of-the-art NMR capabilities
  • Domainex's work on behalf of Auspherix
  • Domainex's future investment round plans
  • How Domainex operates a hybrid business model to generate revenues and reduce burn rate
  • How Domainex plans to partner its TBK1/IKKe programme for the treatment of inflammatory diseases

 

Get the Flash Player to see this video.